# EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)

> **NCT00879866** · PHASE1 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 15 (actual)

## Conditions studied

- Lung Cancer
- Non Small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** EMD 521873

## Key facts

- **NCT ID:** NCT00879866
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-02
- **Final completion:** 2012-09
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00879866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00879866, "EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00879866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*